EBENE C
Acbay O, Gundogdu S. 1996 Can metformin reduce insulin resistance in polycystic ovary syndrome ? Fertil Steril 65: 946-949
Adami S, Zamberlan N, Castello R, Tosi F, Gatti D, Moghetti P. 1998 Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol 48:169-173
Adams J, Polson DW, Franks S. 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293:355-359
Adashi EY, Resnick CE, D`Ercole J, Svoboda ME, Van Wyk JJ. 1985 Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-420
Adashi EY. 1995 Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms. Keio J Med 44:124-132
Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, Tan SL, Campbell S, Jacobs HS. 1998 Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 13:651-655
Albala C, Yanez M, Devoto E, Sostin C, Zeballos L, Santos JL. 1996 Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 20:1027-1032
Albu J, Pi-Sunyer. Obesity and diabetes. 1997 In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong:697-707
Aleem FA, Predanic M. 1996 Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fert Steril 65:510-516
Andersen RE, Wadden TA, Herzog RJ. 1997 Changes in bone mineral content in obese dieting women. Metabolism 46:857-861
Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. 1997 Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa (see comments). Cancer 79:494-499
Anderson RA, Gromme NP, Barid DT. 1998 Inihibin A and inihibin B in women with polycystic ovarian sydnrome during treatment with fsh to induce mono-ovulation. Clin Endocrinol 48:577-584
Anttila L, Karjala K, Penttila RA, Ruutiainen K, Ekblad U. 1998 Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 92:13-16
Apter D, Butzow T, Laughlin GA, Yen SSC 1994 Accalerated 24h LH pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab 79:119-125
Arner P, Eckel RH. 1998 Adipose tissue as a strage organe. In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong: 379-395
Aro A, Jauhiainen M, Partanen R, Salminen I, Mutanen M. 1997 Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr 65:1419-1426
Arroyo A, Laughlin GA, Morales AJ, Yen SS. 1997 Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82:3728-3733
Assmann G, Schulte H. 1992 Relation of high-density lipoprotein cholesterol and triglycerids to incidence of atherosclerotic coronary artery disease (the PROCAM Experience). Am J Cardiol 70:733-737
Assmann G, Cullen P. Nationale Cardiovaskuläre Initiative. 1995 Erkennung und Behandlung von Fettstoffwechselstörungen. Aktuelle Empfehlungen für die Betreuung von Patienten in der Praxis. Beilage zum Deutschen Ärzteblatt 51/52:1-12
Azziz R, Nestler JE, Dewailly, D. Androgen Excess disorders in women. Lippincott-Raven. 1997:
Bailey CJ, Turmer RC. 1996 Metformin.N Eng J Med 334:574-579
Barbieri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50:197-212
Bardin CW, Swerdloff RS, Santen RJ. 1991 Androgens: Risks and benefits. J Clin Endocrinol Metab 73:4-6
Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. 1989 Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320:559-565
Barrett-Connor E, Orchard T. Diabetes and heart disease. 1985 In: Harris HI, Hamman RF, eds. Diabetes in America. Bethesda, Md: National Institutes of Health 1-41. NIH publiation 85-1468
Baumann KL, Butler DE, Deering CF, Mennen KE, Millar A, Nanninga TN, Palmer CW, Roth BD. 1992 The convergent synthetics of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase. Tetrahedron Lett 33:2283-2284
Billig H, Furuta I, Hsueh AJ. 1993 Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133:2204-2212
Birdsall MA, Farquhar CM, White HD. 1997 Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126: 32-35
Björntorp P. 1998 Obesity: a chronic disease with alarming prevalence and consequences. J Intern Med 244:267-269
Boden G. 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
Bongain A, Isnard V, Gillet JY. 1998 Obesity in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 77:217-228
Botwood N, Hamilton-Fairley D, Kiddy D, Robinson S, Franks S. 1995 Sex hormone-binding globulin and female reproductive function. J Steroid Biochem Mol Biol 53:529-531
Bouchard C, 1991 Is weight fluctuation a risk factor? N Eng J Med 324:1887-1889 [comment on: N Engl J Med 1991 324:1839-1844]
Bouchard C, Perusse L, Rice T, Rao DC. 1997 The Genetics of human obesity. In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong: 157-190
Braissant O, Foufelle F, Scotto C, Cauca M, Wahli W. 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137:354-366
Bray GA. Classification and evaluation of the overweight patient. 1997 In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong: 831-854
Brochier ML, Arwidson P. 1998 Coronary heart disease risk factors in women. Eur Heart J 19 Suppl A:A45-52
Buffington CK, Givens JR, Kitabchi AE. 1991 Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes 40:693-700
Burger CW, Korsen T, van Kessel H, van Dop PA, Caron FJ, Schoemaker J. 1985 Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab 61:1126-1132
Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, Dennerstein L, Morse C. 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80:3537-3545
Buring JE, O`Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH. 1992 Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 85:22-29
Caminos-Torres R, Ma L, Snyder PJ 1977 Gynecomastia and semen abnormalities induced by spironolactone in nomral men J Clin Endocrinol Metab 45: 255-260
Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. 1993 Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38:653-658
Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. 1994 Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873-1876
Caro JF. 1991 Clinical review 26: insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 73:691-695
Castelli WP. 1986 The triglycerid issue: a view from framingham. Am Heart J 112:432-437
Castello R, Tosi F, Perrone F, Negri C, Muggeo M, Moghetti P. 1996 Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Fertil Steril 66:734-740
Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. 1997 Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 100:530-537
Chandrasekher YA, Van Dessel HJ, Fauser BC, Giudice LC. 1995 Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. J Clin Endocrinol Metab 80:2734-2739
Chang JR. 1996 Polycysitc ovary syndrome. Springer.
Chen GS, Zhang MY, Wang Q, Ye JC. 1996 Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese. Chung Kuo Yao Li Hsueh Pao 17:407-410
Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM,Palmason C, Cohen RM, Wolever TM. 1996 The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19:1190-1193
Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Olefsky JM, Yen SS. 1997 Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab 82:1421-1425
Ciotta L, Cianci A, Calogero AE, Palumbo MA, Marletta E, Sciuto A, Palumbo G. 1995 Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism. Fertil Steril 64:299-306
Ciotta L, Cianci A, Giuffrida G, Marletta E, Agliano A, Palumbo G. 1996 Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease. Fertil Steril 65:61-67
Colditz GA, Willett WC, Rotnitzky A, Manson JE. 1995 Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481-486
Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. 1992 Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab 71:1355-1360
Consoli A, Nurjhan N, Capani F, Gerich J. 1989 Predominat role of gluconeogenesis in incresed hepatic glucose production in NIDDM. Diabetes 38:550-557
Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. 1992 Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 37:119-125
Conway GS, Avey C, Rumsby G. 1994 The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome. Hum Reprod 9:1681-1683
Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J 1975 Antiandrogenic effect of spironolactones: mechnism of action. Endocrinology 97: 52-58
Couzinet B, Thomas G, Thabalard JC, Brailly S, Schaison G. 1989 Effects of a pure antiandrogen on gonadotropin secretion in normal women and in polycystic ovarian disease. Fertil Steril 52:42-50
Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. 1995 Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women J Clin Endocrinol Metab 80:2057-2062
Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI, Fraser RB. 1997 Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 350:1131-1135
Cusan L, Dupont A, Gomez JL, Trembaly RR, Labrie F. 1994 Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril 61:281-287
Cusi K, Consoli A, DeFronzo RA. 1996 Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4059-4067
Dahlgren E, Friberg LG, Johansson S, Lindstrom B, Oden A, Samsioe G. 1991 Endometrial carcinoma. Ovarian dysfunction - a risk factor in young women. Eur J Obstet Gynecol Reprod Biol. 41:143-150
Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604
Dahlgren E, Johansson S, Lindstedt G, Knuttson F, Oden A, et al. 1992 Women with polycystic ovary syndrome wedge resected in 1956-65. A long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
Dale PO, Tanbo T, Djoseland O, Jervell J, Abyholm T. 1992 Persistence of hyperinsulinaemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist. Acta Endocrinol 126:132-136
Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EL, Tanaka WK. 1994 The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 79:703-706
Daniel SA, Armstrong DT.1986 Androgens in the ovarian microenvironment. Semin Reprod Endocrinol 4:89-100
DeClue TJ, Shah SC, Marchese M, Malone JI. 1991 Insulin resistance and hyperinsulinaemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab 72:1308-1311
DeFronzo RA, Ferramini E. 1991 Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, dyslipisemie, and atherosclerotic cardiovascular disease. Diabetes Care. 14:173-194
DeFronzo RA, Bonadonna RC, Ferrannini E. 1992 Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-366
DeLeo V, Lanzette D, Dantona D, La Marca A, Morgante G. 1998 Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:99-102
Despres J-P, Krauss RM. Obesity and lipoprotein metabolism. 1977 In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong: 651-675
Dewailly D, Robert Y, Helin I, Ardaens Y, Thoams-Desrousseaux P, Lemaitre L, Fossati P. 1994 Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol 41:557-562
Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. 1998 The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab 83:2699-2705
Ditschuneit HH, Flechtner-Mors M, Dolderer M,Fulda U, Ditschuneit H. 1993 Endocrine and metabolic effects of dexfenfluramine in patients with android obesity. Horm Metab Res 25: 573-578
Drent ML. Effects of obesity on endocrine function. 1997 In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker, Inc; New York-Basel-Hong Kong: 753-773
Dunaif A, Graf M.,Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinism. J Clin Endocrinol Metab 65:499-507
Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L. 1991 Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab 73:590-595
Dunn CJ, Peters DH. 1995 Metformin. A review of ist pharmacological properities and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49:721-749
Eden JA, Jones J, Carter GD, Alaghband-Zadeh J. 1988 A comparison of follicular fluid levels of insulin-like growth factor-I in normal dominant and cohort follicles, polycystic and multicystic ovaries. Clin Endocrinol 29:327-336
Edman CD, MacDonald PC. 1978 Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130:456-461
Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. 1997 Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82: 524-530
Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J,Rosenfield RL, Polonsky KS. 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116
Ek I, Arner P, Bergqvist A, Carlstrom K, Wahrenberg H. 1997 Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrom: a possible link to insulin resistance? J Clin Endocrinol Metab 82:1147-1153
Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. 1997 Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab 82:2044-2047
Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J. 1996 Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun. 224:431-437
Erenus M, Gurbuz O, Durmusoglu F, Demircay Z, Pekin S. 1994 Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 61:613-615
Erenus M, Yucelten D, Gurbuz O, Durmusoglu F, Pekin S. 1996 Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Fertil Steril 66:216-219
Erenus M, Yucelten D, Durmusoglu F, Gurbuz O. 1997 Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril 68:1000-1003
Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH 1983 Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57:304-310
Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH 1984 Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33:68-75
Fajas L, Aubeouf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J. 1997 The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272:18779-18789
Falsetti L, Dordoni D, Gastaldi C, Gastaldi A. 1986 A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome. Acta Eur Fertil 17:19-25
Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747
Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
Fitzpatric TB, Arndt KA Clark WH Eisen AZ, Van Scot EJ, Vaughn JH, eds. 1971 Dermatology in general medicine. New York: McGraw-Hill. p1562
Franks S. 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. 1997 The genetic basis of polycystic ovary syndrome. Hum Reprod 12:2641-2648
Friedman AJ, Daly M, Juneau-Norcross M, Rein MS.1992 Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril 58:413-415
Friedl KE. Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids. 1990 In Lin GC, Erinoff I, eds. Anabolic steroid abuse. Washington DC: NIDA Department of Health and Human Services
Fruzzetti F. 1997 Treatment of hirsutism: antiandrogen and 5a -Reductase inhibitor therapy. Androgen excess disorders in women. Lippincott-Raven:787-797
Futterweit W, Deligdisch L. 1986 Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 62:16-21
Gardiner P, Schrode K, Quinlan D, Martin BK, Boreham DR, Rogers MS, Stubbs K, Smith M, Karim A. 1989 Spironolactone metabolism. J Clin Pharmacol 29: 342-347
Geisthövel F, Moretti-Rojas I, Asch RH, Rojas FJ. 1989 Expression of insulin-like growth factor-II (IFG-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granuolsa cells. Hum Reprod 8:899-902
Geisthövel F, Moretti-Rojas I, Rojas FJ, Asch RH. 1990 Insulin-like growth factors and the thecal-granulosa-cell function. Hum Reprod 5:785-799
Geisthövel F. 1992 7. Geschlechtsreife: Intraovarielle Regulation. In: Käser O, Friedberg V, Ober KG, Thomsen K, Zander J (eds). Gynäkologie und Geburtshilfe; Band I, Teil 2: Geschlechtsreife, Sterilität, Frühschwangerschaft, Alter, Psychosomatik: 7.1-7.30
Geisthövel F, Olbrich M, Frorath B, Thiemann M, Weitzell R. 1994 Obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal women. Hum Reprod 9:610-616
Geisthövel F, Frorath B, Brabant G. 1996 Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study. Hum Reprod 11:2377-2381
Geisthövel F. 1997 Diagnostik und Therapie des PCO-Syndroms: Die funktionelle ovarielle Hyperandrogenämie und assoziierte Störungen. In: Allolio B, Grußendorf M, Müller OA, Olbricht T, Schulte HM. IV Intensivkurs für Klinische Gyäkologie, Syllabus. Fortbildungsveranstaltung der Deutschen Gesllschaft für Endokrinologie und der Sektion Angewandte Endokrinologie:221-233
Geisthövel F. 1998 Obesity in female life - from molecular to clinical aspects. In: Schindler (eds) Arch Gynecol: in press
Geisthövel F, Meysing A, Brabant G. 1998 C-peptide and insulin, but not C19-steroids, support the predictive value of body mass index on leptin in serum of premenopausal women. Hum Reprod 13:547-553
Geisthövel F, Meysing A, Horn R, Brabant G. 1998 Bound leptin (bL), leptin receptor (LR), body mass index (BMI), insulin and C19-steroids in premenopausal women. Symposion der Deutschen Gesellschaft für Endokrinologie, Freiburg 5.-7.3., Abstract No
Gibson M. 1995 Reproductive health and polycystic ovary syndrome. Am J Med 98:67S-75S
Gilling-Smith C, Willis DS, Beard RW, Franks S. 1994 Hypersecretion of androstenedione by isolated thecal cells form polycystic ovaries. J Clin Endocrinol Metab 79:1158-1165
Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, Stewart K, Stewart P, Phillips K, Anderson N. 1998 Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA study, protocol 1. Arterioscler Thromb Vasc Biol 18:441-449
Giudice LC, Cataldo NA, van Dessel HJ, Yap OW, Chandrasekher YA. 1996 Growth factors in normal ovarian follicle development. Semin Reprod Endocrinol 14:179-196
Giudice LC. 1997 Role of insulin-like growth factors (IGF) and IGF binding proteins in PCOS. In: Azziz R, Nestler JE, Dewailly, D (eds). Androgen excess disorders in women. Lippincott-Raven:507-519
Globermann H, Karnieli E. 1998 Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance). Int J Obes Relat Metab Disord 22:349-53
Goldschmid MG, Barrett-Connor E, Edelstein SL, Wingard DL, Cohn BA, Herman WH. 1994 Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 89:991-997
Goldzieher JW. 1981 Polycystic ovarian disease. Fertil Steril 35:371-394
Goodman-Gruen D, Barrett-Connor E. 1996 A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. J Clin Endocrinol Metab 81:2999-3003
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. 1977 High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707-714
Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. 1993 Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329:1008-1012
Gregorini SD, Lespi PJ, Alvarez GR. 1997 Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old [article in spanish]. Medicina (B Aires) 57: 209-212
Groome NP, Illingworth PJ, O´Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401-1405
Grunwald K, Rabe T, Schlereth G,Runnebaum B. 1994 Serum hormones before and during therapy with cyproterone acetate and spironolactone in patients with androgenization [article in german] Geburtshilfe Frauenheilkd 54:634-645
Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR. 1983 Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 32:413-420
Haffner SM, Katz MS, Stern MP, Dunn JF. 1989 Association of decreased sex hormone binding globulin and cardiovascular risk factors Arteriosclerosis 9:136-143
Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F. 1975 Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 6: 827-836
Hanefeld M, Willms B. 1996 Diagnosis of the metabolic syndrome. [article in german] Internist 37:705-711
Hayes FJ, Hall JE, Boepple PA, Crowley WF Jr. 1998 Clinical Review 96. Differential control of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endcorinol Metab 83:1835-1841
Hazzard WR. 1993 Why women live longer than men (or why can´t a man be more like a woman?). In: Steinmetz A, Schneider J, Kaffarnik H. (eds). Hormones in lipoprotein metabolism. Berlin, Heidelberg, New York: Springer: 89-97
Heliovaara M, Aromaa A. 1981 Parity and obesity. J Epidemiol Community Health 35:197-199
Hild-Petito S, West NB, Brenner RM, Stouffer RL. 1991 Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biol Reprod 44:561-568
Hillier SG, Ross GT. 1979 Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod 20:261-268
Hillier SG, Tetsuka M, Fraser HM. 1997 Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod 12:107-111
Hirsch J, Leibel RL. 1991 Clinical review 28: A biological basis for human obesity. J Clin Endocrinol Metab 73:1153-1157
Ho SP, Tan KT, Pang MW, Ho TH. 1997 Endometrial hyperplasia and the risk of endometrial carcinoma. Singapore Med J 38:11-15
Hoffmann J, Spengler M, 1997 Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Am J Med 103:483-490
Holte J, Bergh, T, Berne C, Wide L, Lithell H. 1995 Restored Insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:2586-2593
Holte J, Gennarelli G, Wide L, Lithell H, Berne C. 1998 High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 83:1143-1150
Homburg R. 1996 Polycystic ovary syndrome: from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 11:29-39
Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O. 1989 Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol 120:257-265
Hsueh AJ, Billig H, Tsafriri A. 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 6:707-724
Hu E, Tontonoz P, Spiegelman BM. 1995 Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci U S A 92:9856-9860
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willet WC. 1997 Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 20: 1491-1499
Hubert HB, Feinleib M, McNamara PM, Castelli WP. 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977
Hughes BR, Cunliffe WJ. 1998 Tolerance of spironolactone. Br J Dermatol 118:687-691
Imperato-McGinley J, Shackleton C, Orlic S, Stoner E. 1990 C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. J Clin Endocrinol Metab 70:777-782
Imperato-McGinley J, Miller M, Wilson JD, Peterson RE, Shackleton C, Gajdusek DC. 1991 A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf). 34:293-298
Insler V, Lunenfeld B. 1991 Pathophysiology of polycystic ovarian disease: new insights. Hum Reprod 6:1025-1029
Jaatinen TA, Anttila L, Erkkola R, Koskinen P, Laippala P, Ruutiainen K, Scheinin M, Irjala K. 1993 Hormonal responses to physical exercise in patients with polycystic ovarian syndrome. Fertil Steril 60:262-267
Jackson RA, Hawa MI, Jaspen JB, Disilvio L, Featherbe D, Kurtz AB. 1987 Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 36:632-640
James RA. 1998 Octreotide and ectopic Cushing´s syndrome - a commentary. Clin Endocrinol (Oxf) 49:419-420
Janka HU. 1996 Epidemiology of the metabolic syndrome [article in german] Internist 37:681-686
Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. 1992 Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest 89:293-300
Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. 1989 Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83: 1168-1173
Jesionowska H, Hemmings R, Guyda HJ, Posner BI. 1990 Determination of insulin and insulin-like growth factors in the ovarian circulation. Fertil Steril 53:88-91
Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG,Taylor R. 1993 The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism 42:1217-1222
Jones PS, Savory R, Barratt P, Bell AR, Gray TJ, Jenkins NA, Gilbert DJ, Copeland NG, Bell DR. 1995 Chromosomal localitsation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur J Biochem 233:219-226
Kaaks R. 1996 Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605-625
Kadowaki H, Kadowaki T. 1994 Hair-AN syndrome. Review. [article in japanese] Nippon Rinsho - Jap J Clin Med 52:2648-52
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J. 1976 The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man. N Engl J Med 294:739-745
Kannel WB. 1987 Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 114:413-419
Katan MB. 1997 High-oil compared with low-fat, high-carbohydrate diets in the prevention of ischemic heart disease. Am J Clin Nutr 66 (4Suppl):974S-979S
Kazer RR, Unterman TG, Glick RP 1990 An abnormality of the growth hormone/ insulin-like growth factor-I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 71:958-962
Kelestimur F, Sahin Y 1998 Comparison of Diane 35 and Diane 35 plus spironolcatone in the treatment of hirsutism. Fertil Steril 69: 66-69
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36:105-111
Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. 1982 Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260
Kissebah AH, Peiris AN 1989 Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 2:83-109
Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. 1996 Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
Koshida H, Sibata K, Kametani T. 1998 Pleuropulmonary disease in a man with diabetes who was treated with troglitazone. N Eng J Med 339:1400-1401
Kung FT, Chen WJ, Chou HH, Ko SF, Chang SY. 1997 Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 12:1649-1653
Kuttenn F, Mowszowicz I, Schiason G, Mauvais-Jarvis P. 1977 Androgen production and skin metabolism in hirsutism. J Endocrinol 75:83-91
Kyei-Mensah AA, LinTan S, Zaidi J, Jacobs HS. 1998 Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod 13:1437-1441
Laakso M, Lehto S, Penttila I, Pyorala K. 1993 Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430
Lambert-Messerlian G, Taylor A, Leykin L, Isaacson K, Toth T, Chang Y, Schneyer A. 1997 Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol Reprod 57:1211-1216
Lanzone A, Apa R, Fulghesu AM, Cutillo G, Caruso A, Mancuso S. 1993 Long term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome. Fertil Steril 59:734-737
Lanzone A, Villa P, Fulghescu AM, Pavone V, Caruso A, Mancuso S. 1995 The growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinemia. Hum Reprod 10:1653-7
Lea AP, McTavish D. 1997 Atorvastatin: A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 53 (5): 828-847
Lee EJ, Lee BS, Lee HC, Park KH, Song CH, Huh KB. 1993 Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.Fertil Steril 60:53-57
Lee PD, Jensen MD, Divertie GD, Heiling VJ, Katz HH, Conover CC. 1993 Insulin-like growth factor-binding protein-1 response to insulin during suppression of endogenous insulin secretion. Metabolism 42:409-414
Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschar HP. 1994 Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78:1515-20
Legro RS, Muhlemann DR, Comings DE, Lobo RA, Kovacs BW. 1995 A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics. Fertil Steril. 63:779-784
Leidenberger FA. 1997 Klinische Endokrinologie für Frauenärzte. Springer Verlag
Lephart ED, Doody KJ, McPhaul MJ, Simpson ER. 1992 Inverse relationship between ovarian aromatase cytochrome P450 and 5-alpha-reductase enzyme activities and mRNA levels during the estrous cycle in the rat. J Steroid Biochem Mol Biol 42:439-447
Lerner DJ, Kannel WB. 1986 Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383-390
Lewis SJ. 1998 Cholesterol and coronary heart disease in women. Cardiol Clin 16:9-15
Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Duncan BB, Heiss G. 1997 Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin , BMI and WHR. Atherosclerosis risk in communities. Ann Epidemiol 7:407-416
Lobo RA. 1995 A disorder without identity: "HCA", "PCO", "PCOD", "PCOS", "SLS" - what are we to call it? Fertil Steril. 63:1158-1160
Lobo RA. 1996 A unifying concept for polycystic ovary syndrome. In: Chang RJ (ed.). Polycystic ovary syndrome. Springer Verlag:334-352
Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL. 1998 Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy - a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 83:1730-1735
Löönqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P. 1995 A pathogenic role of visceral fat beta-adrenoreceptor in obesity. J Clin Invest 95:1109-1116
Lubbos HG, Hasinski S, Rose LI, Pollock J. 1998 Adverse effects of spironolactone therapy in women with acne. Arch Dermatol 134:1162-1163
Lunenfeld B, Insler V. 1997 An overview of obesity during pregnancy, adolescence and reproduction. Arch Gynecol Obstet 261:31-34
Magoffin DA, Agarawal SK, Jakumiuk AJ. 1996 Suppression of aromatase activity in polycystic ovary syndrome. In: Chang RJ (ed.). Polycystic ovary syndrome. Springer Verlag:208-222
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH. 1990 A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322:882-829
Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. 1995 Body weight and mortality among women. N Engl J Med 333:677-685
Marsden PJ, Murdoch A, Taylor R. 1994 Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. Metabolism 43:1536-1542
Martikainen H, Ruokonen A, Hartikainen AL, Järvelin MR 1998 Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease. Int J Circumpolar Health 57:133-137
Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929
Mason HD, Margara R, Winston RM, Seppala M, Koistinen R, Franks S. 1993 Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-I while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J Clin Endocrinol Metab 76:1275-1279
McBride NM. 1997 Polycystic ovaries and coronary artery disease (letter comment).Ann Intern Med 127:491
McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM. 1987 Circulating immunoreactive inhibin levels during the normal human mentrual cycle. J Clin Endocrinol Metab 65:954-957
Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. 1991 Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 84:1165-1175
Moghetti P, Castello R, Magnani CM, Tosi F, Negri C, Armanini D, Bellotti G, Muggeo M. 1994 Clinical and hormonal effects of the 5alpha-reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab 79:1115-1121
Moghetti P, Castello R, Negri C, Tosi F, Magnani CM, Fontanarosa MC, Armanini D, Muggeo M. 1995 Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 64:511-517
Mogul HR, Marshall M, Frey M, Burke HB, Wynn PE, Wilker S, Southern AL, Gambert SR. 1996 Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 81:4492-4495
Moller DE, Flier JS. 1991 Insulin resistance - mechnisms, syndromes, and implications. N Engl J Med 325:938-948
van Montfrans JM, van Hooff MH, Hompes PG, Lambalk CB 1998 Treatment of hyperinsulinaemia in polycystic ovary syndrome? Hum Reprod 13:5-6
Naether OG, Fischer R, Weise HC, Geiger-Kotzler L, Delfs T, Rudolf K. 1993 Laparoscopic electrocoagulation of the ovarian surface in infertile patients with polycystic ovarian disease. Fertil Steril 60:88-94
Naether OG, Baukloh V, Fischer R, Kowalczyk T. 1994 Long term follow-up in 206 infertility patients with polycystic ovary syndrome after laparoscopic electrocautery of the ovarian surface. Hum Reprod 9:2342-2349
Nagamani M, Stuart CA. 1990 Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis. Am J Obstet Gynecol 163:1992-1997
Nahum R, Thong KJ, Hillier SG. 1995 Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod 10:75-81
Najjar MF, Rowland M. 1987 Anthropometric reference data and prevalence of overweight, United States, 1976-80. Vital Health Stat 11:1-73
National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032
Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89
Nestler JE, Jakubowicz DJ. 1996 Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617-623
Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J.1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193
Nutrition, metabolism and cardiovascular diseases (1992)2:113-156
Öhlin A, Rossner S. 1990 Maternal body weight development after pregnancy. Int J Obes 14:159-173
Ooi GT, Tseng LY-H, Tran MQ, Rechler MM. 1992 Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol 6:2219-2228
Ostlund RE, Staten M, Kohrt WM, Schultz J, Malley M. 1990 The ratio of waist-to-hipcircumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 322:229-234
Orlowski CC, Ooi GT, Brown DR, Yang YW, Tseng LY, Rechler MM. 1991 Insulin rapidly inhibits insulin-like growth factor-binding protein-I gene expression in H4-II-E rat hepatoma cells. Mol Endocrinol 5:1180-1187
Overdiek HW, Hermens WA, Merkus FW.1985 New insights into the pharmacokinetics of spironolactone. Clin Pharmacol Ther 38:469-474
Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB, Fauser BC. 1991 Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology 19:445-452
Pache TD, Hop WC, Wladimiroff JW, Schipper J, Fauser BC. 1991 Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances. Ultrasound Med Biol 17:589-593
Pache TD, Hop WC, de Jong FH, Leerentveld RA, van Geldorp H, Van de Kamp TM, Gooren LJ, Fauser BC. 1992 17 beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol 36:565-571
Pache TD, DeJong FH, Hop WC, Fauser BC. 1993 Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 59:544-549
Panidis D, Skiadopoulos S, Rousso D, Ioannides D, Panidou E. 1995 Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome. Br J Dermatol 132:936-941
Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, Caruso A, Lanzone A. 1998 Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod 13:542-546
Parazzini F, La Vecchia C, Franceschi S, Talamini R, Negri E, Crosignani PG. 1997 Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa (letter comment). Cancer 80:1360-1362
Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR.1997 PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetes subjects Diabetes 46:1230-1234
Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. 1998 Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects. J Clin Endocrinol Metab 83:1636-1643
Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR. 1998 Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 83:2830-2835
Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM. 1997 Determinants of sex hormon-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status Metabolism 46:5-9
Peiris AN, Aiman EJ, Drucker AW, Kissebah AH. 1989 The relative contribution of hepatic and peripheral tissue to insulin resistance in hyperandrogenic women. J Clin Endcrinol Metab 68:715-720
Pekonen F, Laatikainen T, Buyalos R, Rutanen EM. 1989 Decreased 34K insulin-like growth factor-binding protein in polycystic ovarian disease. Fertil Steril 51:972-975
Pettigrew R, Hamilton-Fairley D. 1997 Obesity and female reproductive function. Br Med Bull 53:341-358
Pigny P, Desailloud R, Cortet-Rudelli C, Duhamel A, Deroubaix-Allard D, Racadot A, Dewailly D. 1997 Serum alpha-inhibin levels in polycystic ovary syndrome: relationship to the serum androstenedione level. J Clin Endocrinol Metab 82:1939-1943
Plymate SR, Matej LA, Jones RE, Friedl KE. 1988 Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460-464
Polson DW, Adams J, Steer PJ, Franks S. 1986 Unilateral polycystic ovary. Case report. Br J Obstet Gynaecol 93:1100-1103
Poretsky L, Grigorescu F, Seibel M, Moses AC, Flier S. 1985 Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary. J Clin Endocrinol Metab 61:728-734
Poretsky L. 1991 On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 12:3-13
Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud`Homme D, Lupien PJ, Tremblay A, Bouchard C..1992 Visceral obesity in men: Associations with glucose tolerance , plasma insulin, and lipoprotein levels. Diabetes 41:826-834
Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. 1994 Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73: 460-468
Prelevic GM, Wurzburger MI, Balint-Peric L, Puzigaca Z. 1989 Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome. Gynecol Endocrinol 3:269-280
Prelevic GM, Wurzburger MI, Balint-Peric L, Nesic J. 1990 Inhibitory effect of sandostatin on secretion of luteinizing-hormone and ovarian steroids in polycystic ovary syndrome. Lancet 336:900-903
Prelevic GM, Wurzburger MI, Balint-Peric L, Ginsburg J. 1992 Twenty-four-hour serum growth hormone, insulin, C-peptide, and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 37:125-131
Prelevic GM, Ginsburg J, Maletic D, Hardiman P, Okolo S, Balint-Peric L, Thomas M, Orskov H. 1995 The effects of somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Hum Reprod 10:28-32
Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. 1993 Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study. J Clin Endocrinol Metab 76:283-287
Puzigaca Z, Prelevic GM, Stretenovic Z, Balint-Peric L. 1991 Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol Endocrinol 5:167-174
Quigley ME, Rakoff JS, Yen SS. 1981 Increased luteinizing hormone sensitivity to dopamine inhibition in polycystic ovary syndrome. J Clin Endocrinol Metab 52:231-234
Ramasharma K, Cabrera CM, Li CH. 1986 Identification of insulin-like growth factor-II in human seminal and follicular fluids. Biochem Biophys Res Commun 140:536-542
Ramasharma K, Li CH. 1987 Human pituitary and placental hormones control human insulin-like growth factor II secretion in human granulosa cells. Proc Natl Acad Sci U S A 84:2643-2647
Reaven GM. 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. 1988 Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024
Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320-1329
Regan L, Owen EJ, Jacobs HS. 1990 Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 336:1141-1144
Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF. 1992 Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J Clin Endocrinol Metab 75:45-51
Reid IR, Plank LD, Evans MC. 1992 Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779-782
Richards GE, Cavallo A, Meyer WJ, Prince MJ, Peters EJ, Stuart CA, Smith ER. 1985 Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history. J Pediatr 107:893-897
Rittmaster RS. 1994 Finasteride. N Engl J Med 330:120-125
Rittmaster RS. 1995 Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results. J Clin Endocrinol Metab 80:3403-3405
Rittmaster RS. 1997 Peripheral actions of androgens In: Azziz R, Nestler JE, Dewailly D (eds). Androgen excess disorders in women. Lippincott-Raven:63-71
Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, Dewailly D. 1995 Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 64:307-312
Ronnemaa T, Koskenvuo M, Marniemi J, Koivunen T, Sajantila A, Rissanen A, Kaitsaari M, Bouchard C, Kaprio J. 1997 Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J Clin Endocrinol Metab 82:383-387
Rosenfield RL, Barnes RB, Cara JF, Lucky AW. 1990 Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril 53:785-791
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. 1989 Sequential changes in serum insulin concentration during develeopment of non-insulin-dependent diabetes. Lancet I:356-1359
Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S. 1988 Recurrent early miscarriage and polycystic ovaries. Br Med J 297:1027-1028
Salha O, Martin-Hirsch P, Lane G. Sharma V. 1997 Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer. Hum Reprod 12:959-962
San Roman GA, Magoffin DA. 1992 Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 75:1010-1016
San Roman GA, Magoffin DA. 1993 Insulin-like growth factor binding proteins in healthy and atretic follicles during natural menstrual cycles. J Clin Endocrinol Metab 76:625-632
Sasson Z, Rasooly Y, Bhesania T, Rasooly I. 1993 Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 88:1431-1436
Schoonjans K, Staels B, Auwerx J. 1996a The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109
Schoonjans K, Staels B, Auwerx J. 1996b Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925
Seppala M, Wahlstrom T, Koskimies AI, Tenhunen A, Rutanen EM, Koistinen R, Huhtaniemi I, Bohn H, Stenman UH. 1984 Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles and corpus luteum contain placental protein 12. J Clin Endocrinol Metab 58:505-510
Serafini P, Lobo RA. 1985 Increased 5 alpha-reductase activity in idiopathic hirsutism. Fertil Steril 43:74-78
Shaw RW. 1989 Use of nafarelin to investigate the pathophysiology of the polycystic ovary syndrome. J Reprod Med 34:1039-1043
Sherif K, Kushner H, Falkner BE. 1998 Sex hormone-binding globulin and insulin resistance in African-American women. Metabolism 47:70-74
Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP 1-6). Prog Growth Factor Res 3:243-266
Shoham Z, Conway GS, Patel A, Jacobs HS. 1992 Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovary syndrome. Fertil Steril 58:37-45
Sobel BE. 1996 Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert. Circulation 93:1613-1615
Spencer CM, Markham A. 1997 Troglitazone. Drugs 54:89-101
Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ. 1989 The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab 69:151-157
Standl E. 1996 Metabolic syndrome and fatal quartet [article in german]. Internist 37:698-704
Stein IF, Leventhal ML. 1935 Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181-191
Stephens J, Carey AH, Short F, Williamson R, Franks S. 1993 Premature balding, the male phenotype of polycystic ovaries. J Clin Endocrinol 139:31
Stuart CA, Peters EJ, Prince MJ, Richards G, Cavallo A, Meyer WJ. 1986 Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. Metabolism 35: 197-205
Stubb S, Kariniemi AL. 1995 Drug-induced skin reactions [article in Finnish]. Duodecim 111:971-977
Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. 1995 Metabolic effects of metformin in non-insulin dependent diabetes mellitus. N Engl J Med 333:550-554
Suikkari AM, Koivisto VA, Rutanen EM, Yki-Larvinen H, Karonen SL, Seppala M. 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272
Suikkari A, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989 Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 68:135-140
Suikkari AM, Ruutainen K, Erkkola R, Seppala M. 1989 Low levels of low-molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian diseaese. Hum Reprod 4:136-139
Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. 1997 Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans.J Nutr 127:514S-520S
Suzuki M, Ikebuchi M, Shinozaki K, Hara Y, Tsushima M, Matsuyama T, Harano Y. 1996 Mechanism and clinical implication of insulin resistance syndrome. Diabetes 45 (Suppl 3) S52-S54
Swanson M, Sauerbrei EE, Cooperberg PL. 1981 Medical implications of utrasonically detected polycystic ovaries. J Clin Ultrasound 9:219-222
Taggart HM, Applebaum-Bowden D, Haffner S, Warnick GR, Cheung MC, Albers JJ, Chestnut CH, Hazzard WR. 1982 Reduction in high density lipoproteins by anabolic steroid (stanozol) therapy for postmenopausal osteoporosis. Metabolism 31:1147-1152
Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L. 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
Talbott E, Clerice A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA. 1998 Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51:415-422
Tapanainen J, Ronnberg L, Martikainen H, Reinila M, Koistinen R, Seppala M. 1991 Short and long term effects of growth hormone on circulating levels of insulin-like growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study. J Clin Endocrinol Metab 73:71-74
Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. 1993 Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.J Clin Invest 92:903-910
Tremblay RR. 1986 Treatment of hirsutism with spironolactone. Clin Endocrinol Metab 15: 363-371
Troisi R, Potischman N, Hoover RN, Siiteri P, Brinton LA.1997 Insulin and endometrial cancer. Am J Epidemiol 146:476-482
UK Prospectice Daibetes Study (UKPDS) Group. 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865
Urman B, Sarac E, Dogan L, Gurgan T. 1997 Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 42:501-505
Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilating normal menses and pregnancy. Metabolism 43:647-654
Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. 1998 Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101:2622-2629
Voutilainen R, Miller WL. 1987 Coordinate trophic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. Proc Natl Acad Sci U S A 84:1590-1594
Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF Jr. 1988 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 66:165-172
Weaver JU, Holly JM, Kopelman PG, Noonan K, Giadom CG, White N, Virdee S, Wass JA. 1990 Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor-binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol 33:415-422
Webb OL, Laskarzewski PM, Glueck CJ. 1984 Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33:971-975
Wechsler JG.1997 Diätetische Therapie der Adipositas. Dt Ärztebl 94:A2250-A2256
Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WF Jr, Smith JA, Schoenfeld DA, Hall JE. 1997 Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 82:2645-2652
Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M. 1990 Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 54:255-259
Wild RA. 1994 Cardiovascular disease risks, insulin resistance, and androgen excess. Semin Reprod Endocrinol 12:38-44
Wing RR, Matthews KA, Kuller LH, Smith D, Becker D, Plantinga PL, Meilahn EN. 1992 Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. JAMA 268:1890-1895
Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH. 1997 Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes. Int J Obes Relat Metab Disord 21:756-763
Wong IL, Morris RS, Chang L, Spahn MA, Stanczyk FZ, Lobo RA. 1995 A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J Clin Endocrinol Metab 80:233-238
Wortsman J, Wehrenberg WB, Gavin JR, Allen JP. 1984 Elevated levels of plasma beta-endorphin and gamma 3-menalocyte stimulating hormone in the polycystic ovary syndrome. Obstet Gynecol 63:630-634
Wortsman J, de Angeles S, Futterweit W, Singh KB, Kaufmann RC. 1991 Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 36:659-661
Wu MS, Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, Chen YD, Reaven GM. 1990 Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1-8
Wüster C, von zur Mühlen A, Ranke MB. 1994 Das Syndrom des Wachstumshormonmangels beim Erwachsenen. Therapiebedürftige Erkrankung oder altersphysiologische Veränderung ? Dt Ärztebl 91:A2402-A2408
Yen SS, Vela P, Rankin J. 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30:435-442
Yen SS. 1980 The polycystic ovary syndrome. Clin Endocrinol 12:177-207
Yen SS. 1991 Chronic anovulation caused by peripheral endocrine disorders. In Yen SSC, Jaffe RB (eds). Reproductive Endoogy, 3rd edition. Saunders Co, Philadelphia, p. 576-630.
Yen SS, Laughlin GA, Morales AJ. 1993 Interface between extra- and intraovarian factors in polycystic ovarian syndrome. Ann N Y Acad Sci 28: 98-111
Yesalis CE, Cowart VS. The steroids game. Champaign,Ill.: Human Kinetics, 1998
Ying SY. 1988 Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293
Young MA, Lettis S, Eastmond R. 1998 Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food. Br J Clin Pharmacol 45:31-35
Young MA, Lettis S, Eastmond R. 1998 Concomitant administration of cholestyramine influences the absorption of troglitazone. Br J Clin Pharmacol 45:37-40
Zhang LH, Rodriguez H, Ohno S, Miller WL. 1995 Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci U S A 92:10619-10623
Zaidi J, Campbell SC, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. 1995 Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum Reprod 10:1992-1996
Zavaroni I, Bonora E, Pagliara M, Dall´Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G. 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706
Zhou J, Chin E, Bondy C. 1991 Cellular pattern of insulin-like growth factor-I (IGF I) and IGF I receptor gene expression in the developing and mature ovarian follicle. Endocrinology. 129:3281-3288